• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B族链球菌表面蛋白作为保护性抗体的靶点:血清型V菌株中两种新蛋白的鉴定。

Group B streptococcal surface proteins as targets for protective antibodies: identification of two novel proteins in strains of serotype V.

作者信息

Areschoug T, Stålhammar-Carlemalm M, Larsson C, Lindahl G

机构信息

Department of Laboratory Medicine, Lund University, S-22362 Lund, Sweden.

出版信息

Infect Immun. 1999 Dec;67(12):6350-7. doi: 10.1128/IAI.67.12.6350-6357.1999.

DOI:10.1128/IAI.67.12.6350-6357.1999
PMID:10569749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC97041/
Abstract

Strains of group B streptococcus (GBS) express surface proteins that confer protective immunity. In particular, most strains of the four classical capsular serotypes (Ia, Ib, II, and III) express either of the Rib and alpha proteins, two members of the same protein family. Here, we report a study of surface proteins expressed by strains of serotype V, which has recently emerged as an important serotype among GBS strains causing serious disease. Two novel GBS proteins were identified, purified, and characterized. One of these proteins, designated Fbs, was immunologically unrelated to other GBS surface proteins. This approximately 110-kDa protein was found in 15 of 49 (31%) type V isolates but in few strains of other serotypes. The Fbs proteins expressed by different strains showed limited variation in size. The most common surface protein among type V strains, found in 29 of 49 (59%) isolates, was designated Rib-like, since it cross-reacted with Rib but was not immunologically identical to Rib. Characterization of this Rib-like protein showed that the N-terminal sequence (12 residues) was identical to that of alpha, although these two proteins lacked cross-reactivity. The biochemical and immunological properties of the Rib-like GBS protein indicate that it is closely related to the R28 protein of Streptococcus pyogenes. Importantly, passive and active immunization experiments with mice showed that the Fbs and Rib-like proteins are targets for protective antibodies. These two proteins are therefore of interest for analysis of pathogenic mechanisms and for vaccine development.

摘要

B族链球菌(GBS)菌株表达具有保护性免疫的表面蛋白。特别是,四种经典荚膜血清型(Ia、Ib、II和III)的大多数菌株表达Rib和α蛋白中的一种,这两种蛋白属于同一蛋白家族。在此,我们报告了一项关于血清型V菌株所表达表面蛋白的研究,血清型V最近已成为引起严重疾病的GBS菌株中的一种重要血清型。鉴定、纯化并表征了两种新型GBS蛋白。其中一种蛋白命名为Fbs,在免疫上与其他GBS表面蛋白无关。这种约110 kDa的蛋白在49株V型分离株中的15株(31%)中被发现,但在其他血清型的菌株中很少见。不同菌株表达的Fbs蛋白在大小上变化有限。在49株V型菌株中的29株(59%)中发现的最常见表面蛋白被命名为类Rib蛋白,因为它与Rib发生交叉反应,但在免疫上与Rib并不相同。对这种类Rib蛋白的表征表明,其N端序列(12个残基)与α蛋白的N端序列相同,尽管这两种蛋白缺乏交叉反应性。类Rib GBS蛋白的生化和免疫特性表明它与化脓性链球菌的R28蛋白密切相关。重要的是,对小鼠进行的被动和主动免疫实验表明,Fbs和类Rib蛋白是保护性抗体的靶点。因此,这两种蛋白对于致病机制分析和疫苗开发具有重要意义。

相似文献

1
Group B streptococcal surface proteins as targets for protective antibodies: identification of two novel proteins in strains of serotype V.B族链球菌表面蛋白作为保护性抗体的靶点:血清型V菌株中两种新蛋白的鉴定。
Infect Immun. 1999 Dec;67(12):6350-7. doi: 10.1128/IAI.67.12.6350-6357.1999.
2
Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections.蛋白质核糖:一种新型B族链球菌细胞表面蛋白,可提供保护性免疫,且大多数引起侵袭性感染的菌株都可表达该蛋白。
J Exp Med. 1993 Jun 1;177(6):1593-603. doi: 10.1084/jem.177.6.1593.
3
Cross-protection between group A and group B streptococci due to cross-reacting surface proteins.由于交叉反应性表面蛋白导致的A组和B组链球菌之间的交叉保护作用。
J Infect Dis. 2000 Jul;182(1):142-9. doi: 10.1086/315693. Epub 2000 Jun 30.
4
A protective surface protein from type V group B streptococci shares N-terminal sequence homology with the alpha C protein.来自B族V型链球菌的一种保护性表面蛋白与αC蛋白具有N端序列同源性。
Infect Immun. 1996 Oct;64(10):4255-60. doi: 10.1128/iai.64.10.4255-4260.1996.
5
Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha.用细胞表面蛋白Rib和α的高度纯化制剂对B族链球菌(一种有荚膜的细菌)进行实验性疫苗接种。
Infect Immun. 1996 Sep;64(9):3518-23. doi: 10.1128/iai.64.9.3518-3523.1996.
6
Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci.B族链球菌新型细胞表面保护性抗原——B族保护性表面蛋白的分子分析
Infect Immun. 2002 Feb;70(2):803-11. doi: 10.1128/IAI.70.2.803-811.2002.
7
Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine.用二价蛋白疫苗免疫预防B族链球菌实验性感染
Vaccine. 1999 Feb 5;17(5):454-8. doi: 10.1016/s0264-410x(98)00218-7.
8
Putative novel surface-exposed Streptococcus agalactiae protein frequently expressed by the group B streptococcus from Zimbabwe.津巴布韦B族链球菌频繁表达的假定新型表面暴露无乳链球菌蛋白。
Clin Vaccine Immunol. 2009 Sep;16(9):1302-8. doi: 10.1128/CVI.00133-09. Epub 2009 Jul 8.
9
Immunological markers of the R4 protein of Streptococcus agalactiae.无乳链球菌R4蛋白的免疫标记物
Clin Diagn Lab Immunol. 2005 Nov;12(11):1305-10. doi: 10.1128/CDLI.12.11.1305-1310.2005.
10
Temperature-Induced Self-Assembly of the Group B Streptococcus (GBS) Fusion Antigen GBS-NN.温度诱导的 B 族链球菌(GBS)融合抗原 GBS-NN 的自组装。
Mol Pharm. 2018 Jul 2;15(7):2584-2593. doi: 10.1021/acs.molpharmaceut.8b00101. Epub 2018 May 31.

引用本文的文献

1
Group B Streptococcus: Virulence Factors and Pathogenic Mechanism.B族链球菌:毒力因子与致病机制
Microorganisms. 2022 Dec 15;10(12):2483. doi: 10.3390/microorganisms10122483.
2
A Vaccine Against Group B : Recent Advances.一种针对B族的疫苗:最新进展
Infect Drug Resist. 2020 Apr 29;13:1263-1272. doi: 10.2147/IDR.S203454. eCollection 2020.
3
Reverse immunodynamics: a new method for identifying targets of protective immunity.反向免疫动力学:一种鉴定保护性免疫靶标的新方法。
Sci Rep. 2019 Feb 15;9(1):2164. doi: 10.1038/s41598-018-37288-x.
4
Status of group B streptococcal vaccine development.B族链球菌疫苗的研发现状。
Clin Exp Vaccine Res. 2018 Jan;7(1):76-81. doi: 10.7774/cevr.2018.7.1.76. Epub 2018 Jan 29.
5
Vaccination With a Latch Peptide Provides Serotype-Independent Protection Against Group B Streptococcus Infection in Mice. latch 肽疫苗接种为小鼠提供针对 B 族链球菌感染的血清型非依赖性保护。
J Infect Dis. 2017 Dec 27;217(1):93-102. doi: 10.1093/infdis/jix565.
6
Phenotypic and genotypic characterization of Streptococcus agalactiae in pregnant women. First study in a province of Argentina.孕妇中无乳链球菌的表型和基因型特征。阿根廷一省的首次研究。
Braz J Microbiol. 2013 May 17;44(1):253-8. doi: 10.1590/S1517-83822013005000030. eCollection 2013.
7
Novel aspects of the Z and R3 antigens of Streptococcus agalactiae revealed by immunological testing.通过免疫检测揭示的无乳链球菌Z和R3抗原的新特性
Clin Vaccine Immunol. 2013 Apr;20(4):607-12. doi: 10.1128/CVI.00581-12. Epub 2013 Feb 13.
8
Streptococcus agalactiae alpha-like protein 1 possesses both cross-reacting and Alp1-specific epitopes.无乳链球菌α样蛋白1具有交叉反应性表位和Alp1特异性表位。
Clin Vaccine Immunol. 2011 Aug;18(8):1365-70. doi: 10.1128/CVI.05005-11. Epub 2011 Jun 8.
9
Putative novel surface-exposed Streptococcus agalactiae protein frequently expressed by the group B streptococcus from Zimbabwe.津巴布韦B族链球菌频繁表达的假定新型表面暴露无乳链球菌蛋白。
Clin Vaccine Immunol. 2009 Sep;16(9):1302-8. doi: 10.1128/CVI.00133-09. Epub 2009 Jul 8.
10
Distinctive features of surface-anchored proteins of Streptococcus agalactiae strains from Zimbabwe revealed by PCR and dot blotting.通过聚合酶链反应(PCR)和斑点印迹法揭示的来自津巴布韦的无乳链球菌菌株表面锚定蛋白的独特特征。
Clin Vaccine Immunol. 2008 Sep;15(9):1420-4. doi: 10.1128/CVI.00112-08. Epub 2008 Jul 30.

本文引用的文献

1
The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells.化脓性链球菌的R28蛋白与几种B族链球菌表面蛋白相关,具有保护性免疫作用,并促进与人上皮细胞的结合。
Mol Microbiol. 1999 Jul;33(1):208-19. doi: 10.1046/j.1365-2958.1999.01470.x.
2
Capsular sialic acid limits C5a production on type III group B streptococci.荚膜唾液酸限制B族链球菌III型菌株上C5a的产生。
Infect Immun. 1999 Apr;67(4):1866-70. doi: 10.1128/IAI.67.4.1866-1870.1999.
3
Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine.用二价蛋白疫苗免疫预防B族链球菌实验性感染
Vaccine. 1999 Feb 5;17(5):454-8. doi: 10.1016/s0264-410x(98)00218-7.
4
Epidemiology of group B streptococcal disease in the United States: shifting paradigms.美国B族链球菌病的流行病学:不断变化的模式
Clin Microbiol Rev. 1998 Jul;11(3):497-513. doi: 10.1128/CMR.11.3.497.
5
Chaos, persistence, and evolution of strain structure in antigenically diverse infectious agents.抗原性多样的感染因子中菌株结构的混沌、持久性和进化
Science. 1998 May 8;280(5365):912-5. doi: 10.1126/science.280.5365.912.
6
Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program.马里兰州侵袭性B族链球菌分离株的血清型分布:对疫苗配方的影响。马里兰州新发感染项目。
J Infect Dis. 1998 Apr;177(4):998-1002. doi: 10.1086/515260.
7
Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infection.早发型全身感染新生儿B族链球菌分离株的荚膜多糖类型
J Infect Dis. 1998 Mar;177(3):790-2. doi: 10.1086/517810.
8
Group B streptococcal meningitis in adults: report of twelve cases and review.成人B族链球菌性脑膜炎:12例报告及文献复习
Clin Infect Dis. 1997 Nov;25(5):1180-7. doi: 10.1086/516094.
9
A protective surface protein from type V group B streptococci shares N-terminal sequence homology with the alpha C protein.来自B族V型链球菌的一种保护性表面蛋白与αC蛋白具有N端序列同源性。
Infect Immun. 1996 Oct;64(10):4255-60. doi: 10.1128/iai.64.10.4255-4260.1996.
10
Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha.用细胞表面蛋白Rib和α的高度纯化制剂对B族链球菌(一种有荚膜的细菌)进行实验性疫苗接种。
Infect Immun. 1996 Sep;64(9):3518-23. doi: 10.1128/iai.64.9.3518-3523.1996.